PanTheryx Revenue and Competitors

Boulder, CO USA

Location

$138M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • PanTheryx's estimated annual revenue is currently $4M per year.(i)
  • PanTheryx's estimated revenue per employee is $100,500
  • PanTheryx's total funding is $138M.

Employee Data

  • PanTheryx has 40 Employees.(i)
  • PanTheryx grew their employee count by -11% last year.

PanTheryx's People

NameTitleEmail/Phone
1
ControllerReveal Email/Phone
2
SVP, ELN Business Development and QualityReveal Email/Phone
3
SVP SalesReveal Email/Phone
4
EVP & Global Supply Chain OfficerReveal Email/Phone
5
Sr. Director Business Planning and ITReveal Email/Phone
6
President & CEO; Board DirectorReveal Email/Phone
7
Director Planning & ProcurementReveal Email/Phone
8
Director Operations, Bulk Powder & MaintenanceReveal Email/Phone
9
Director Sales, Human NutritionReveal Email/Phone
10
Director SalesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M250%N/AN/A
#2
$10.3M516%N/AN/A
#3
$4.4M22-8%N/AN/A
#4
$195M1220%$121.4MN/A
#5
$4.8M24-20%N/AN/A
#6
$6.8M34-19%N/AN/A
#7
$4.8M240%N/AN/A
#8
$4M40-11%$138MN/A
#9
$4.8M24-14%N/AN/A
#10
$69.5M346-6%N/AN/A
Add Company

What Is PanTheryx?

PanTheryx is a medical nutrition company committed to realizing the potential of nutrition-based interventions to address a wide range of serious GI microbiome related health conditions. Our team is dedicated to investing in research that will further validate our patented technology platform, and generate scientific evidence to support the potential of nutritional ingredients, like colostrum to support good health and influence a broad range of diseases and conditions.

keywords:Biotechnology

$138M

Total Funding

40

Number of Employees

$4M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PanTheryx News

2022-04-17 - PanTheryx debuts novel colostrum and probiotic combination

Currently, Pantheryx is running stability trials to prove the viability of the probiotic strains with colostrum over time. He said so far they...

2022-04-06 - Despite railing against Big Tech and Big Pharma, records show Dr. Oz has invested millions in both

... and between $500,000 and $1 million in shares of Pantheryx, a biotechnology company that specializes in bovine colostrum products.

2022-03-30 - PanTheryx Expands Formulation Capabilities to Include ...

PanTheryx's new probiotic formulations can be applied to dietary supplements. ... PanTheryx controls every stage of its colostrum production...

2019-06-27 - PanTheryx Raises $50 Million From Perceptive Advisors

BOULDER, Colo.--(BUSINESS WIRE)--PanTheryx, a biotechnology company focused on addressing serious GI related health conditions, announced today that it has completed $50 million in new financing with Perceptive Advisors. Proceeds from the financing will be used to accelerate development of novel ...

2019-06-27 - PanTheryx Raises $50M in Financing

PanTheryx, a Boulder, CO-based biotechnology company focused on addressing serious GI related health conditions, completed a $50m financing round. Perceptive Advisors made the investment, which brings the total financing raised by PanTheryx to $170 million. The company intends to use the funds ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.6M408%N/A
#2
$4.5M40-20%N/A
#3
$3.5M40-9%N/A
#4
$4.9M400%N/A
#5
$3.5M400%N/A